期刊文献+

维甲酸对宫颈癌细胞耐药株增殖及药物敏感性的影响 被引量:1

Effects of all trans-retinoic acid on proliferation and chemosensitivity of drug resistant cervix carcinoma cell
下载PDF
导出
摘要 目的:探讨全反式维甲酸(ATRA)对宫颈癌耐药株HeLa/MMC的增殖及药物敏感性的影响及其作用的分子机制。方法:观察ATRA作用下HeLa/MMC细胞的增殖,MTT法观察ATRA对HeLa/MMC药物敏感性的影响,半定量RT-PCR检测mdr1基因的表达情况。结果:①ATRA对HeLa/MMC细胞的增殖有抑制作用,这一作用为非细胞毒抑制作用。②ATRA能提高MMC对HeLa/MMC细胞的杀伤作用,并呈剂量依赖性。③半定量RT-PCR结果显示,ATRA上调了HeLa/MMC细胞mdr1基因的表达。结论:表明ATRA能抑制HeLa/MMC的增殖,提高HeLa/MMC对MMC的敏感性,但这种作用与mdr1基因表达无关。 Objective: To investigate the proliferation and chemosensitivity in human cervical carcinoma cell HeLa/MMC of drug resistance by all - trans - retinoic acid and illustrate its molecular mechanism. Methods: The proliferation was observed after treatment with ATRA. The effects of ATRA on drug sensitivity in Hela/MMC cells were studied by MTr colorimetry assay. The change of mdr1 mRNA levels was determined by semiquantitative RT-PCR. Results:①ATRA can inhibit proliferation of Hela/MMC cells without cytotoxicity. ②ATRA could enhance the eytotoxicity of MMC in Hela/MMC cells in the manner of dose dependence. ③The expression levels of mdr1 mRNA increased in compared with that of the control after treatment with ATRA by semiquantitative RT-PCR. Conclusion : ATRA can inhibit the proliferation and improve the ehemosensitivity to HeLa/MMC, but this reversal mechanism is not associated with the expression levels of mdr1 gene.
出处 《海南医学院学报》 CAS 2008年第2期119-121,共3页 Journal of Hainan Medical University
关键词 宫颈肿瘤 维甲酸 丝裂霉素 四甲基偶氮唑盐比色法 聚合酶链反应 Cervix tumors Retinoic acid Mitomycin C MTT Polymerase chain reaction
  • 相关文献

参考文献3

  • 1Hatae M, Kanda E, Nakamura J, et al. Chemotherapy for cervical carcinoma [ J ]. GAN To Kagaku Ryoho, 2005,32 (8) :1104-1109.
  • 2Scheffer GL, Scheper RJ. Drug resistance molecules: lessons from oncology [ J ]. Novartis Found Symp, 2002,243 : 19-31.
  • 3Garrigues A, Loiseau N, Delaforge M, et al. Characterization of two pharmacyophores on the multidrug transporter P - glycoprotein [ J ]. Mol Pharrnacol,2002,62 (6) : 1288-1298.

同被引文献7

  • 1Kawamata H,Tachibana M,Fujimori T. Differentiation-inducing therapy for solid tumors[J].Current Pharmaceutical Design,2006,(03):379-385.
  • 2Mark M,Ghyselinck NB,Chambon P. Function of retinoid nuclear receptors:lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis[J].Annual Review of Pharmacology and Toxicology,2006.451-458.
  • 3Okuno M,Kojima S,Matsushima-Nishiwaki R. Retinoids in cancer chemoprevention[J].Curr Cancer Drug Target,2004.285-298.
  • 4Anne S,Tsao MD,Edward SK. Chemoprevention of Cancer[J].CA:A Cancer Journal for Clinicians,2004.150-180.
  • 5Jemal A,Murray T,Ward E. Cancer statistics,2005[J].CA:A Cancer Journal for Clinicians,2005,(01):10-30.
  • 6Abu J,Batuwangala M,Herbert K. Retinoid receptors:potential chemopreventive and therapeutic role in cervical cancer[J].Lence Oncol,2005,(09):712-720.
  • 7Bibi Petersen,Gregor BE Jemec. Alitretinoin-its use in intractable hand eczema and other potential indications[J].Drug Design Development and Therapy,2009,(03).

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部